Epidural hydroxyethyl starch to prevent post-dural puncture headache in parturients
Official title: Effect of Epidural Hydroxyethyl Starch Administration for Prevention of Post-Dural Puncture Headache in Parturients: A Multi-center Prospective Cohort Study
Run by Peking University First Hospital · NCT07914790 · Data updated 2026-11-12
This study tests whether filling the epidural space with hydroxyethyl starch can help prevent post-dural puncture headaches in women who had an accidental dural puncture during epidural anesthesia for labor or cesarean delivery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 410 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 4 sites (Beijing, Beijing Municipality and 3 other locations) |
| Status | Recruiting |
| Started | November 4, 2026 |
| Main results expected | December 2029 |
| Study ends | June 2030 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07914790 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult parturients (age ≥18) who experience accidental dural puncture during epidural labor analgesia or neuraxial anesthesia for cesarean delivery.
✕Probably not a fit
Patients without ADP or those not receiving epidural catheter-based interventions may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter prospective cohort project investigates the effect of epidural hydroxyethyl starch (HES) filling on preventing PDPH after accidental dural puncture in parturients. Participants are women aged 18 or older who experienced ADP during neuraxial anesthesia for labor analgesia or cesarean delivery. The study compares outcomes between those receiving TEG/epidural HES filling and those who do not, across several Chinese hospitals. Background data describe the incidence of ADP and PDPH, current conservative and pharmacologic treatments, and the rationale for using epidural HES to reduce CSF leakage. The study design is observational, focusing on real-world practice across multiple centers to assess feasibility and potential benefit. Primary endpoints likely include incidence and severity of PDPH, with secondary outcomes on analgesic requirements and recovery metrics.
Why it matters
Potential benefit: If successful, epidural HES filling could reduce the risk or severity of PDPH in parturients who experience ADP, potentially improving comfort and recovery.
How similar studies have gone: Previous reports describe the use of epidural filling with HES to prevent PDPH, but robust prospective data in parturients are limited, making this evaluation relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years. 2. Have experienced accidental dural puncture (ADP) during epidural labor analgesia or neuraxial anesthesia for cesarean delivery. Exclusion Criteria: 1. Age \<18 years. 2. ASA physical status ≥IV. 3. Cesarean delivery under general anesthesia. 4. Preoperative inability to communicate due to intellectual or language impairment. 5. Pre-existing cerebrovascular disease, migraine, or chronic headache. 6. Long-term use of oral analgesics. 7. Preoperative coagulation dysfunction. 8. Platelet count \<80×10⁹/L. 9. Refusal to participate.
Where it's running
-
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing Haidian Maternal and Child Health Hospital
Beijing, Beijing Municipality, China Not yet recruiting -
Ningxia Maternal and Child Health Hospital
Yinchuan, Ningxia, China Not yet recruiting -
Taiyuan central hospital
Taiyuan, Shanxi, China Not yet recruiting
Study contacts
- Principal investigator: Dong-Xin Wang, MD, PhD — Peking University First Hospital
- Study coordinator: Zhi-Yu Geng, MD
- Email: gengzhiyu2013@163.com
- Phone: 86 10 83572460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Post-Dural Puncture Headache After Spinal Anesthesia in Cesarean Deliveries
This study tests whether changes in optic nerve sheath diameter after spinal anesthesia can predict who will develop a post-dural puncture headache in pregnant women having an elective cesarean.
-
Treating post-dural puncture headache with theophylline, sumatriptan, or gabapentin
This trial will try theophylline, sumatriptan, and gabapentin to see which best relieves moderate-to-severe post-dural puncture headache in adults aged 21–50.
-
Sphenopalatine ganglion block versus epidural blood patch for post-dural puncture headache
This test compares a sphenopalatine ganglion block and an epidural blood patch to see which relieves post-dural puncture headaches better in adults whose pain hasn't improved after 24 hours of usual treatment.
-
Nebulized neostigmine/atropine versus nebulized lidocaine for post-dural puncture headache after cesarean delivery
This trial tests whether inhaled (nebulized) neostigmine with atropine relieves post-dural puncture headache better than inhaled lidocaine in women who develop headache after spinal anesthesia for elective cesarean delivery.
-
Exploring causes and treatments for postural puncture headache
This study is trying to understand what causes post-dural puncture headaches and how treatments like epidural blood patches can help people who get them after a lumbar puncture.
-
Impact of altitude on headaches after cesarean delivery
This study is testing how living at different altitudes affects the headaches that women experience after having a cesarean delivery with spinal anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.